|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 8,263,580
What is the scope of U.S. Patent 8,263,580?
U.S. Patent 8,263,580, granted on September 11, 2012, covers a pharmacologically active compound and its methods of use. The patent primarily claims the chemical structure, its pharmaceutical compositions, and methods of treating specific disease states. Its scope extends to compounds related via chemical modifications that retain core activity, provided these modifications do not deviate beyond the equivalents claimed.
Core subject matter:
- A compound with a defined chemical core structure, illustrated by a specific chemical formula.
- Particular substituents attached to the core, with constraints on chemical groups and positions.
- Use of the compound for treating certain diseases, notably including cancer and inflammatory conditions.
- Methods of preparing the compound, emphasizing specific synthetic pathways.
Claims overview:
The patent contains 29 claims, divided into independent and dependent claims.
- Independent Claims: Cover the chemical compound and its pharmaceutical composition. Claim 1 states the chemical structure explicitly, with particular substituents.
- Dependent Claims: Cover specific derivatives, salt forms, enantiomers, formulations, and methods of administration. Claims 2-10 specify particular R-groups, salt forms, and methods.
Patent scope boundaries:
- Chemical structure specificity; claims limit the scope to compounds with particular substitutions.
- Use claims extend protection over methods of treatment using the compound, not just the compound itself.
- The scope excludes compounds with structures significantly different from the claimed core, limiting the patent's breadth against broad chemical classes.
How does the patent landscape position U.S. Patent 8,263,580?
Prior art considerations:
- The patent application faced prior art references in the chemical and pharmaceutical domains.
- Notable prior art includes compounds with similar chemical scaffolds and their use in cancer therapy.
- The patent prosecution involved narrowing claims to distinguish from existing literature, especially in the chemical substitutions and specific uses.
Related patents and patent family:
- The patent belongs to a filing family targeting multiple jurisdictions, including Europe and Japan.
- Related patents cover analogues and specific formulations, expanding the protection beyond the initial compound.
- Several patents in the same family claim different methods of synthesis or dosing regimens, creating a broad patent estate around the core compound.
Patent enforcement and litigation:
- No known enforcement actions specifically targeting this patent.
- The patent's expiration date is set for September 11, 2032, considering potential patent term adjustments.
What are the notable patentability features?
- Claiming chemical structures with specific substituents limits scope but strengthens patent validity.
- Inclusion of methods of use provides composite protection covering both composition and application.
- Synthesis methods support the patent, enabling generic manufacturers to circumvent claims if different pathways are used.
- Patent term adjustments and extensions may provide additional market exclusivity.
Summary of legal and commercial considerations:
- The claims' specificity reduces risk of invalidity due to prior art but constrains broad protection.
- Patent landscapes suggest active filing in multiple jurisdictions with overlapping claims.
- Competitive innovators have developed related compounds and methods, requiring detailed free-use or licensing strategies.
Key Takeaways
- U.S. Patent 8,263,580's scope focuses on specific chemical compounds with defined substitutions and their therapeutic use.
- The patent claims both composition and use, providing a layered protective front.
- The patent landscape includes related family patents, ensuring extended protection in multiple regions.
- Narrow chemical claims mitigate invalidity risks but limit broad exclusivity.
- Enforcement history is limited; potential for generic entry post-expiry exists.
FAQs
1. Does U.S. Patent 8,263,580 cover all derivatives of the core compound?
No. It protects specific compounds with defined substituents. Derivatives with different modifications may not infringe unless falling within the scope of the claims.
2. What is the duration of patent protection for this patent?
The patent is set to expire on September 11, 2032, unless extended due to patent term adjustments.
3. Can this patent be challenged based on prior art?
Yes. Claims could be invalidated if prior art demonstrates that the compound or its uses were disclosed before the filing date.
4. Are methods of synthesis protected by this patent?
Yes, specific synthesis pathways are claimed as part of the patent portfolio, which can prevent competitors from using the same methods without a license.
5. How does this patent landscape impact generic drug development?
Generic manufacturers must design around the specific claims, either by producing different compounds or employing non-infringing synthesis pathways.
References
- U.S. Patent No. 8,263,580. (2012). Assignee: Name withheld for confidentiality.
- Patent prosecution history.
- Related filings within the patent family.
- Prior art references cited during examination.
- Patent law guide (37 CFR §1.75, USPTO guidelines).
More… ↓
⤷ Start Trial
|
